15-Year safety watch for cell therapy recipients

NCT ID NCT03391778

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: USWM CT, LLC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 2 times

Summary

This study tracks the long-term safety of people who have already received a type of cell therapy called ADP adoptive cell therapy. Researchers will monitor up to 250 participants for up to 15 years after their last treatment to see if any delayed side effects occur. The goal is to better understand the long-term risks of this therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEOPLASMS

Contacts and locations

Locations

ADP Investigational Site

Baltimore, Maryland, 21201, United States
Antoni Van Leeuwenhoek Ziekenhuis

Amsterdam, 1066 CX, Netherlands
Duke University Medical Center

Durham, North Carolina, 27710, United States
Emory University School of Medicine

Atlanta, Georgia, 30322, United States
Fondazione IRCCS - Istituto Nazionale dei Tumori

Milan, Lombardy, 20133, Italy
Froedtert Hospital

Milwaukee, Wisconsin, 53226, United States
Hospital Universitario Virgen del Rocío

Seville, 41013, Spain
Hôpital Maisonneuve-Rosemont

Montreal, Quebec, H1T 2M4, Canada
Klinikum rechts der Isar der Technischen Universität München

Munich, Bavaria, 81377, Germany
Memorial Sloan Kettering Cancer Center - New York

New York, New York, 10065, United States
National Cancer Institute - Center for Cancer Research

Bethesda, Maryland, 20892, United States
Oregon Health and Science University

Portland, Oregon, 97239, United States
Peter MacCallum Cancer Centre

Melbourne, Victoria, 3000, Australia
Princess Margaret Cancer Centre

Toronto, Ontario, M5G 2M9, Canada
The Royal Marsden NHS Foundation Trust

Sutton, SM2 5PT, United Kingdom
USWM CT Investigational Site

Manchester, M20 4BX, United Kingdom
Uniklinik Köln

Cologne, North Rhine-Westphalia, 50937, Germany
University College London Hospitals NHS Foundation Trust

London, NW1 2PG, United Kingdom
University of Michigan

Ann Arbor, Michigan, 48109, United States
University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States
University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center

Pittsburgh, Pennsylvania, 15232, United States
University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States
University of Texas Southwestern Medical Center

Dallas, Texas, 75390, United States
Washington University School of Medicine in St. Louis

St Louis, Missouri, 63110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.